PureTech advanced its KarXT treatment through its own founded entity KarunaTherapeutics, which was acquired by Bristol Myers Squibb in March. Along with a royalty agreement with Royalty Pharma ...
The U.S. Food and Drug Administration late Thursday approved a new kind of drug to treat schizophrenia, a breakthrough after 70 years of incremental innovation that appears to avoid side effects ...
Results that may be inaccessible to you are currently showing.